8.29.05: Diagnostic Tools & Services Report
3 analysts and top management from 4 firms examine the Diagnostic Tools & Services sector in this 30 page report from The Wall Street Transcript.

  1. Diagnostic Tools & Services: Frank Pinkerton Jr., Banc of America Securities

  2. Life Sciences Tools & Molecular Diagnostics: Adam Chazan, Pacific Growth Equities

  3. Diagnostic Manufacturers: William Quirk, RBC Capital Markets

  4. CEO Interviews (average 2,500 words): Top management from 4 sector firms examine the outlook for their firm and the sector. Firms interviewed include: Bio-Reference Laboratories, Biosite Inc., Creative Computer Applications and EXACT Sciences.

    Topics covered: FDA approvals  - Genotyping technologies  - R&D spending  - Government funding  - M&A activity  - Shift toward automation  - Investors concerns  - Internal growth rates 

    Companies covered: Roche (RHHVF), Invitrogen (IVGN), Millipore (MIL), Serologicals (SERO), Abbott Laboratories (ABT), Bayer (BAY), Olympus (OCPNF), Johnson & Johnson (JNJ), Quest Diagnostics (DGX), Laboratory Corp. of America (LH), Invitrogen (IVGN), Illumina (ILMN), Third Wave Technologies (TWTI), Gen-Probe (GPRO), Quest Diagnostics (DGX), Ciphergen Biosystems (CIPH), Dade Behring (DADE), Beckman Coulter (BEC), Diagnostic Products (DP), Immucor (BLUD) and NeuroMetrix (NURO).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
           		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE